0001567619-20-001083.txt : 20200115 0001567619-20-001083.hdr.sgml : 20200115 20200115152752 ACCESSION NUMBER: 0001567619-20-001083 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200115 DATE AS OF CHANGE: 20200115 EFFECTIVENESS DATE: 20200115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALZHEON, INC. CENTRAL INDEX KEY: 0001582636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463074149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358146 FILM NUMBER: 20528204 BUSINESS ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 857-214-7242 MAIL ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 D 1 primary_doc.xml X0708 D LIVE 0001582636 ALZHEON, INC. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 508-861-7709 DELAWARE None None Corporation true Martin Tolar, M.D., Ph.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Executive Officer President and Chief Executive Officer Kenneth A. Mace 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Treasurer/VP Finance Neil W. Flanzraich 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Jordan Heller 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director David Nikodem, Ph.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Noel Dunn 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Diane K. Jorkasky, M.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Biotechnology Decline to Disclose 06b false 2019-04-25 true true true Conversion of Convertible Promissory Notes false 0 6163716 6163716 0 Total Offering Amount and Total Amount Sold also include the conversion of Promissory Notes. false 13 0 0 0 false ALZHEON, INC. /s/ Martin Tolar, M.D., Ph.D. Martin Tolar, M.D., Ph.D. President and Chief Executive Officer 2020-01-15